Researchers developed and validated ElasticNet machine learning models that predict 12-month MMSE and BADL outcomes in ...
Validating drug production processes need not be a headache, according to AI researchers who say machine learning (ML) could be a single answer to biopharma’s multivariate problem. The FDA defines ...
Feasibility and efficacy of a pharmacist-led video consultation to identify drug interactions among patients initiating oral anti-cancer drugs. This is an ASCO Meeting Abstract from the 2023 ASCO ...
In a breakthrough for cardiovascular medicine, researchers have harnessed artificial intelligence to discover unexpected lipid-lowering effects in existing FDA-approved drugs. The study, published in ...
Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
†PLCO and LFL (p <.05). ††LF and LFL (p <.05). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...
Interview Kickstart Publishes Comprehensive 2026 Career Guide. A structured roadmap outlines how infrastructure expertise translates into ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results